NasdaqCM - Delayed Quote USD
Cyclacel Pharmaceuticals, Inc. (CYCCP)
4.8700
+0.0700
+(1.46%)
As of April 23 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,990
-7,990
-16,112
-20,827
-18,540
Investing Cash Flow
--
--
-6
-7
-27
Financing Cash Flow
7,822
7,822
848
2,998
21,737
End Cash Position
3,137
3,137
3,378
18,345
36,559
Income Tax Paid Supplemental Data
2
2
2
2
--
Interest Paid Supplemental Data
270
--
--
--
--
Capital Expenditure
--
--
-6
-7
-27
Issuance of Capital Stock
6,209
6,209
1,049
3,199
17,371
Free Cash Flow
-7,990
-7,990
-16,118
-20,834
-18,567
12/31/2021 - 11/30/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RKVTF RAKOVINA THERAPEUTICS INC
0.0360
-0.28%
ARMP Armata Pharmaceuticals, Inc.
1.3719
+4.16%
CYCN Cyclerion Therapeutics, Inc.
2.8300
-4.07%
ORGS Orgenesis Inc.
2.4900
+12.67%
TOVX Theriva Biologics, Inc.
1.4099
-1.41%
ATHE Alterity Therapeutics Limited
3.4990
-0.60%
AVTX Avalo Therapeutics, Inc.
4.9150
-0.71%
CAMP CAMP4 THERAPEUTICS CORPORATION
1.9850
+0.25%
TCRT Alaunos Therapeutics, Inc.
2.6700
+8.54%
ZVSA ZyVersa Therapeutics, Inc.
0.7378
+4.79%